Notice: Trying to access array offset on value of type null in /home/innovational/domains/innovationaljournals.com/public_html/plugins/themes/default/DefaultThemePlugin.inc.php on line 163
View of The future of cancer immunotherapy: Advances in checkpoint inhibitors and chimeric antigen receptor-T cells discussing recent progress in immunotherapy for cancer, focusing on checkpoint inhibitors and chimeric antigen receptor-T cell therapies